Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer.
Authors: Won HS; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim YS; Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Seo KJ; Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jun SY; Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Sun S; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Choi M; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yoon JS; Clinical Research Laboratory, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Byun JH; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Source: Frontiers in oncology [Front Oncol] 2025 Aug 18; Vol. 15, pp. 1638758. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1638758